Technology provides procedure efficiencies for congenital heart disease patients
WASHINGTON, DC (April 30, 2021) - Analysis of a new international registry shows the benefits of using a longer-covered stent for interventional procedures in patients with congenital heart disease with Sinus Venosus Atrial Septal Defect (SVASD). The study was unveiled today as groundbreaking clinical research at the Society for Cardiovascular Angiography & Interventions (SCAI) 2021 Scientific Sessions. SVASD is a rare congenital heart disease in adults that allows blood to move from the systemic to the pulmonary circulation, causing excessive blood flow to the lungs. To date, open heart surgical repair has been the gold standard for managing this condition, but it is necessarily invasive. Covered stent implantation is a recently developed interventional procedure that can replace open heart surgery in some of these patients. However, according to the study's authors, there is no such thing as an "ideal stent" in which physicians frequently have to modify